vTv Therapeutics (VTVT) EBT Margin (2014 - 2026)

vTv Therapeutics has disclosed EBT Margin across 11 years of filings, most recently posting 65.51% for Q1 2026.

• EBT Margin for Q1 2026 came in at 65.51%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 1.98% (up 13472155.0% YoY), and the FY2024 annual result was 2222.71%, changed N/A from the prior year.
• EBT Margin came in at 65.51% for Q1 2026 at vTv Therapeutics, up from 26100.0% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 65.51% in Q1 2026 to a low of 67666.67% in Q4 2022.
• The 3-year median for EBT Margin is 13345.95% (2024), against an average of 23368.3%.
• Peak annual rise in EBT Margin reached 3770000 bps in 2022, while the deepest fall reached 3611111 bps in 2022.
• vTv Therapeutics' EBT Margin stood at 67666.67% in 2022, then jumped by 61 bps to 26100.0% in 2024, then soared by 100 bps to 65.51% in 2026.
• The last three EBT Margin figures came in at 65.51% (Q1 2026), 26100.0% (Q4 2024), and 591.9% (Q1 2024), per Business Quant data.